Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Call to discuss its First Quarter 2024 Financial Results and Business Updates.
Autolus Stock: Faces FDA Decision On CAR-T Therapy in November seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2023 Financial Results Conference Call and Business Update.
Autolus Therapeutics plc (NASDAQ:AUTL) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2023 Financial Results Conference Call and Business Update. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please […]
Obe-cel, a potentially transformational treatment for relapsed/refractory adult B-cell Acute Lymphoblastic Leukemia , on track for a Biologics License Application submission to the US Food & Drug.